Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Chantix Faces FDA Safety Gauntlet After Pfizer Settles Product Liability Suits

Apr 25 2014

• By Brenda Sandburg

Related Content

Chantix, Zyban Need Safety Studies In Patients With Mental Illness

Jul 01 2009

FDA: Suicide Risk For Users Of Pfizer’s Anti-Smoking Drug Chantix

Feb 01 2008

FDA Reviewing Chantix Postmarketing Data On Suicide, Erratic Behavior

Nov 20 2007

Pfizer Litigation Strategy: Business Focus, Legal Alliance Drive Successes

Mar 03 2014

Related Companies

Pfizer Inc.

GSK plc

Additional Topics

Regulation Post Market Regulation & Studies Advisory Committees BioPharmaceutical

More from Post-Marketing Regulation & Studies

More from Product Reviews

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window